# Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis

> **NCT01486979** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 58 (actual)

## Conditions studied

- Menopause
- Postmenopausal Vaginal Atrophy

## Interventions

- **DRUG:** estradiol, 10 mcg
- **DRUG:** estradiol, 25 mcg

## Key facts

- **NCT ID:** NCT01486979
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2017-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01486979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01486979, "Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01486979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*